Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Bolus Surfactant on Perfusion and TCO in Preterm Infants
NCT01923844Phase 4Completed
- Sponsor
- Ege University
- Start
- Mar 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Poractant alfa, beractant in respiratory distress syndrome (RDS), sponsored by Ege University. Started Mar 2012; status: completed.
02
Drugs
Poractant alfaberactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT01923844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923844.